vimarsana.com
Home
Live Updates
Takeover set to spur ocular therapies to marketplace : vimar
Takeover set to spur ocular therapies to marketplace : vimar
Takeover set to spur ocular therapies to marketplace
Gyroscope Therapeutics Holdings, a portfolio company of life sciences investment trust Syncona Ltd, has been acquired by Novartis for up to $1. Click to read more...
Related Keywords
United Kingdom ,
Chris Hollowood ,
Syncona Investment Management ,
Syncona Ltd ,
Gyroscope Therapeutics Holdings ,
Novartis ,
Chief Investment Officer ,
Syncona Investment Management Limited ,
Pound ,
Gyroscope ,
Company ,
Development ,
Investment ,
Linical ,
Potential ,
Syncona ,
Hase ,
Transaction ,